Overview

Efficacy Study of Low-Dose Hydrocortisone Treatment for Fibromyalgia

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This study is based on clinical findings that some patients with fibromyalgia have a tendency towards lower levels of the stress hormone cortisol. The hypothesis to be tested in this study is that the administration of a very low-dose of cortisol which has no side effects corrects this deficiency and results in an improvement of symptoms
Phase:
Early Phase 1
Details
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Collaborator:
University of Zurich
Treatments:
Cortisol succinate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate